← Back to Clinical Trials
Recruiting NCT06883981

NCT06883981 Capturing Autobiographical Memory Formation in Real World Spaces Using Multimodal Recordings

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06883981
Status Recruiting
Phase
Sponsor University of Utah
Condition Epilepsy
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-01-30
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Free and Cued Recall Memory. Temporal Sequence and Spatial Memory

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-01-30 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to develop novel methods for integrating multimodal data streams with invasive neural recordings to study autobiographical memory (AM) formation in individuals with implanted neurostimulation devices (e.g., NeuroPace RNS) for epilepsy treatment. The main questions it aims to answer are: How does the brain encode and retrieve real-world autobiographical memories? Can multimodal data integration enhance our understanding of memory-related cognitive and neural mechanisms? Participants will: * Use a smartphone-based recording application (CAPTURE app) to collect real-world data. * Have their wearable sensor data (e.g., audio-visual, accelerometry, GPS, autonomic physiology, eye tracking) synchronized with invasive neural recordings. Researchers will analyze these multimodal data streams to develop new analytic approaches for studying memory formation in naturalistic settings, with the long-term goal of informing neuromodulation-based memory enhancement treatments for individuals with memory disorders.

Eligibility Criteria

Inclusion Criteria: * 18 years of age or older * healthy to minor cognitive impairment Exclusion Criteria: * younger than 18 years of age * more than minor cognitive impairment

Contact & Investigator

Central Contact

Alireza Kazemi, PhD

✉ alireza.kazemi@utah.edu

📞 5303040970

Frequently Asked Questions

Who can join the NCT06883981 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06883981 currently recruiting?

Yes, NCT06883981 is actively recruiting participants. Contact the research team at alireza.kazemi@utah.edu for enrollment information.

Where is the NCT06883981 trial being conducted?

This trial is being conducted at Salt Lake City, United States.

Who is sponsoring the NCT06883981 clinical trial?

NCT06883981 is sponsored by University of Utah. The trial plans to enroll 50 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology